Subscribe to our Newsletters !!
Drug quality is defined not only how a drug is man
Eppendorf is launching the new VisioNize® box 2,
The journey and merging of sperm and egg cells is
This year, the Hamburg based life sciences company
Alembic Pharmaceutica
Since it’s an ingredient in so many foods, you h
In a world constantly in motion, Microbioz India r
Researchers in the US have found a potential therapeutic treatment for SARS-CoV-2, the virus which causes COVID-19, along with other coronaviruses. Pathogenic coronaviruses are a major threat to international public health, as shown by the SARS-CoV, MERS-CoV, along with the recently emerged SARS-CoV-2.
All these coronavirus 3C-like proteases, called 3CLpro, are strong therapeutic targets because they play vital roles in coronavirus replication, ” the researchers stated.
“Vaccine developments and treatments are the biggest targets in COVID-19 research, and therapy is actually key,” explained Kyeong-Ok Chang, a professor at Kansas State University in the US.
“This paper clarifies protease inhibitors targeting coronavirus 3CLpro, that can be a well-known therapeutic goal,” Chang explained.
These findings imply that this series of chemicals should be researched further as a potential therapeutic for human coronavirus infection, they said.
